Non-invasive monitoring of smoldering multiple myeloma Published 2020-12-05 Download video MP4 360p Download video MP4 720p Recommendations 04:15 Talquetamab: GPRC5D-CD3 bispecific antibody in R/R myeloma 18:46 Approach to the Exam for Parkinson's Disease 01:28 Studying Bloom Syndrome 04:31 Understanding Parkinson's disease 00:49 Genomic differences between smoldering and multiple myeloma 04:10 Reigniting Hope to Reclaim Movement 18:40 Matthew Perry's Death From Ketamine Explained (Is It Safe For You?) 24:07 Sjogren's Syndrome Affects the Brain and Spine 07:14 CAR-Ts in multiple myeloma: their current role and the future 14:46 Excess Deaths at Night - Obstructive Sleep Apnea Explained Clearly 00:54 New hope for patients with incurable and disabling Dupuytren’s disease 01:23 What are the side effects of immunotherapy? 04:45 Orthopaedics in Oxford 05:50 Immunotherapy and breast cancer: how does it work? 04:15 The role of bone marrow stromal cells in myeloma progression and drug resistance 01:11 An update to the risk stratification of MGUS, SMM, and multiple myeloma 03:35 Precision medicine and Oxford, challenges and opportunities - Sir John Bell GBE 01:32 What types of cancer can immunotherapy treat? 03:44 Association between elevated WBC counts and thrombotic events in polycythemia vera 02:18 The EMN22 trial: daratumumab monotherapy in newly diagnosed stage 3B AL amyloidosis Similar videos 03:07 Non-invasive monitoring of smoldering multiple myeloma: The iMMunocell study 01:23 Non-invasive liquid biopsy to assess myeloma precursor disease pathology 1:02:06 Interpreting MGUS/Smoldering Myeloma Labs- What To Know and When To Take Action 02:52 Genomically aggressive or indolent smoldering myeloma and progression to multiple myeloma 58:44 Treatments Available for High Risk Smoldering Myeloma Patients 50:47 Monitoring Circulating Plasma Cells in routine diagnostics in Multiple Myeloma 01:28 Risk stratification models for smoldering myeloma 01:04 Better understanding smoldering myeloma & improving the outcomes of patients with high-risk myeloma 01:53 CureCloud: liquid biopsy sequencing for multiple myeloma 01:41 Mitigating smoldering myeloma progression risk 02:01 Can circulating tumor cell assessment by flow replace bone marrow aspirates to monitor SMM? 28:42 Implications of CMMC Counts in Multiple Myeloma Patient Monitoring 03:15 NGS identifies smoldering multiple myeloma patients with a high risk of disease progression 03:00 Genomic features of myeloma precursor conditions can predict clinical progression 02:10 Why should smoldering myeloma be treated early? 55:03 Digital Infoday Session: Smouldering myeloma 20:03 BCMA: Predicting Outcomes and Monitoring MM and CLL 15:38 New tools for multiple myeloma treatment monitoring 52:17 “Smoldering Myeloma and an Opportunity for Screening” by Timothy O’Brien, MD More results